Preferred Label : pharmacology;

MeSH synonym : mechanism of action; mode of action; pharmacodynamics; pharmacologic action;

Details


Main resources

You can consult :


http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003959/human_med_002054.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
brodalumab
antibodies, monoclonal
brodalumab
drug approval
europe
treatment outcome
psoriasis
adult
injections, subcutaneous
Prefilled Syringe Dosage Form
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
receptors, interleukin-17
receptors, interleukin-17
IL17RA protein, human
brodalumab
antibodies, monoclonal

---
Refixia - nonacog beta pegol
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004178/human_med_002107.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
nonacog beta pegol
nonacog beta pegol
coagulation factor IX
treatment outcome
product surveillance, postmarketing
hemorrhage
hemorrhage
hemophilia B
hemophilia B
adult
adolescent
aged
injections, intravenous
drug evaluation, preclinical
factor IX
polyethylene glycols
recombinant proteins
factor IX
polyethylene glycols
recombinant proteins

---
Veltassa patiromer
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004180/human_med_002141.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
patiromer
drug approval
europe
treatment outcome
patiromer calcium
product surveillance, postmarketing
polymers
adult
hyperkalemia
powders
administration, oral
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
patiromer
polymers

---
Summary Basis of Decision (SBD) for Adlyxine
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00363
2017
false
Canada
English
French
Glucagon-Like Peptide-1 Receptor
lixisenatide
canada
drug information
drug approval
treatment outcome
adult
diabetes mellitus, type 2
drug therapy, combination
hypoglycemic agents
injections, subcutaneous
lixisenatide
lixisenatide
peptides
peptides

---
Summary Basis of Decision (SBD) for Ozanex
Ozenoxacin cream 1% w/w, topical
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00358
2017
false
false
false
Canada
French
drug information
ozenoxacin
administration, cutaneous
drug approval
canada
treatment outcome
ozenoxacin
anti-bacterial agents
anti-bacterial agents
impetigo
infant
child
adolescent
adult
other antibiotics for topical use
ointments
aminopyridines
quinolones
aminopyridines
quinolones

---
Summary Basis of Decision (SBD) for Tecentriq
Atezolizumab 1200 mg/vial, solution, intravenous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00356
2017
false
false
false
Canada
French
English
atezolizumab
drug information
atezolizumab
drug approval
canada
treatment outcome
antineoplastic agents
antineoplastic agents
neoplasm metastasis
Locally Advanced Malignant Neoplasm
Urothelial Carcinoma
disease progression
adult
aged
infusions, intravenous
antigens, CD274
antibodies, monoclonal, humanized
urinary bladder neoplasms
CD274 protein, human
antibodies, monoclonal, humanized

---
Summary Basis of Decision (SBD) for Istodax
Romidepsin, 10 mg/vial, lyophilized powder for solution, intravenous infusion
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00256
2017
false
false
false
Canada
French
English
romidepsin
romidepsin
romidepsin
drug approval
canada
treatment outcome
infusions, intravenous
Romidepsin 10mg injection solution (product)
antibiotics, antineoplastic
antibiotics, antineoplastic
lymphoma, T-Cell, peripheral
recurrence
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
histone deacetylase inhibitors
histone deacetylase inhibitors
drug information
depsipeptides
depsipeptides

---
Summary Basis of Decision (SBD) for Rexulti
Brexpiprazole 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00353
2017
false
false
false
Canada
French
drug information
brexpiprazole
brexpiprazole
drug approval
canada
treatment outcome
schizophrenia
antipsychotic agents
adult
aged
brexpiprazole
antipsychotic agents
tablets
administration, oral
thiophenes
quinolones
thiophenes
quinolones

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004729/human_med_002116.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Rituximab
Rituximab
biosimilar pharmaceuticals
Granulomatosis with Polyangiitis
microscopic polyangiitis
lymphoma, large B-Cell, diffuse
leukemia, lymphocytic, chronic, B-Cell
Rituximab 10mg/mL injection concentrate 10mL vial (product)
Rituximab 10mg/mL infusion concentrate 50mL vial (product)
antineoplastic agents
lymphoma, follicular
treatment outcome
infusions, intravenous
antigens, CD20
arthritis, rheumatoid
adult
aged
antirheumatic agents
drug interactions
pregnancy
breast feeding
antineoplastic agents
antirheumatic agents
drug therapy, combination
drug evaluation, preclinical
drug approval
rituximab
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003903/human_med_002095.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Rituximab
Rituximab
biosimilar pharmaceuticals
Granulomatosis with Polyangiitis
microscopic polyangiitis
lymphoma, large B-Cell, diffuse
leukemia, lymphocytic, chronic, B-Cell
Rituximab 10mg/mL injection concentrate 10mL vial (product)
Rituximab 10mg/mL infusion concentrate 50mL vial (product)
antineoplastic agents
lymphoma, follicular
treatment outcome
infusions, intravenous
antigens, CD20
arthritis, rheumatoid
adult
aged
antirheumatic agents
drug interactions
pregnancy
breast feeding
antineoplastic agents
antirheumatic agents
drug therapy, combination
drug evaluation, preclinical
drug approval
rituximab
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004723/human_med_002125.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Rituximab
Rituximab
biosimilar pharmaceuticals
Granulomatosis with Polyangiitis
microscopic polyangiitis
lymphoma, large B-Cell, diffuse
leukemia, lymphocytic, chronic, B-Cell
Rituximab 10mg/mL infusion concentrate 50mL vial (product)
antineoplastic agents
lymphoma, follicular
treatment outcome
infusions, intravenous
antigens, CD20
adult
aged
drug interactions
pregnancy
breast feeding
antineoplastic agents
drug therapy, combination
drug evaluation, preclinical
drug approval
rituximab
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004725/human_med_002137.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Rituximab
Rituximab
biosimilar pharmaceuticals
Granulomatosis with Polyangiitis
microscopic polyangiitis
lymphoma, large B-Cell, diffuse
Rituximab 10mg/mL infusion concentrate 50mL vial (product)
antineoplastic agents
lymphoma, follicular
treatment outcome
infusions, intravenous
antigens, CD20
adult
aged
drug interactions
pregnancy
breast feeding
antineoplastic agents
drug therapy, combination
drug evaluation, preclinical
drug approval
rituximab
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004724/human_med_002140.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Rituximab
Rituximab
biosimilar pharmaceuticals
Granulomatosis with Polyangiitis
microscopic polyangiitis
lymphoma, large B-Cell, diffuse
leukemia, lymphocytic, chronic, B-Cell
Rituximab 10mg/mL infusion concentrate 50mL vial (product)
antineoplastic agents
lymphoma, follicular
treatment outcome
infusions, intravenous
antigens, CD20
adult
aged
drug interactions
pregnancy
breast feeding
antineoplastic agents
drug therapy, combination
drug evaluation, preclinical
drug approval
rituximab
package leaflet
summary of product characteristics
drug evaluation

---
https://www.has-sante.fr/portail/jcms/c_2792203/fr/zinplava
2017
false
false
false
France
French
antibodies, monoclonal
antibodies, monoclonal
treatment outcome
antibodies, neutralizing
antibodies, neutralizing
adult
bezlotoxumab
toxB protein, clostridium difficile
infusions, intravenous
recurrence
aged
immunocompromised host
evaluation of the transparency committee
Clostridium difficile infection
drug therapy, combination
anti-bacterial agents
clostridium infections
clostridium difficile
clostridium infections
vancomycin
metronidazole
At risk for relapse (finding)
risk
clostridium infections
diarrhea
Clostridium difficile diarrhea (disorder)
bacterial proteins
bacterial toxins

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004213/human_med_002149.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
ribociclib
ribociclib
protein kinase inhibitors
neoplasm metastasis
Locally Advanced Malignant Neoplasm
antineoplastic agents
antineoplastic agents
Locally advanced breast cancer
breast neoplasms
postmenopause
Stage IV Breast Cancer
Hormone receptor positive malignant neoplasm of breast (disorder)
administration, oral
HER2/Neu Negative
Cyclin-Dependent kinase 4
Cyclin-Dependent kinase 6
protein kinase inhibitors
protein kinase inhibitors
drug monitoring
product surveillance, postmarketing
antineoplastic combined chemotherapy protocols
adult
aged
drug interactions
drug evaluation, preclinical
aminopyridines
purines
aminopyridines
purines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002770/human_med_002136.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
cariprazine
cariprazine
cariprazine
drug monitoring
product surveillance, postmarketing
schizophrenia
antipsychotic agents
antipsychotic agents
adult
administration, oral
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
piperazines
piperazines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004230/human_med_002150.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
drug evaluation
drug approval
europe
cladribine
cladribine
immunosuppressive agents
immunosuppressive agents
adult
multiple sclerosis
administration, oral

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004279/human_med_002147.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Adalimumab
Adalimumab
biosimilar pharmaceuticals
psoriasis
crohn disease
Axial spondyloarthritis
colitis, ulcerative
arthritis, juvenile
Enthesitis-related arthritis
hidradenitis suppurativa
uveitis
drug approval
antirheumatic agents
anti-inflammatory agents
tumor necrosis factor-alpha
drug evaluation, preclinical
arthritis, rheumatoid
arthritis, psoriatic
spondylitis, ankylosing
drug interactions
pregnancy
breast feeding
antirheumatic agents
anti-inflammatory agents
adult
treatment outcome
drug evaluation
injections, subcutaneous
adalimumab
summary of product characteristics
drug evaluation
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004391/human_med_002165.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
Darunavir
Cobicistat
drug approval
europe
treatment outcome
Emtricitabine
tenofovir alafenamide
anti-hiv agents
anti-hiv agents
hiv infections
product surveillance, postmarketing
adult
adolescent
administration, oral
tablets
Cytochrome P-450 CYP3A Inhibitors
Cytochrome P-450 CYP3A Inhibitors
hiv protease inhibitors
hiv protease inhibitors
reverse transcriptase inhibitors
reverse transcriptase inhibitors
GS-7340
antivirals for systemic use
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
Tenofovir
Darunavir
Cobicistat
tenofovir alafenamide
Emtricitabine
GS-7340
adenine

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004350/human_med_002153.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
sulfonamides
sulfonamides
macrocyclic compounds
macrocyclic compounds
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
drug approval
europe
treatment outcome
direct acting antivirals
product surveillance, postmarketing
administration, oral
hepatitis C, chronic
antiviral agents
antiviral agents
adult
drug interactions
pregnancy
breast feeding
NS-5 protein, hepatitis C virus
NS-5a protein, hepatitis C virus
Hepatitis C virus NS3/4A protease inhibitor (substance)
viral nonstructural proteins
serine proteases
drug evaluation, preclinical
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004143/human_med_002166.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
atezolizumab
atezolizumab
drug approval
treatment outcome
antineoplastic agents
antineoplastic agents
neoplasm metastasis
Locally Advanced Malignant Neoplasm
Bladder Urothelial Carcinoma
disease progression
adult
aged
infusions, intravenous
antigens, CD274
antibodies, monoclonal, humanized
syndication feed
summary of product characteristics
package leaflet
drug evaluation
CD274 protein, human
europe
carcinoma, non-small-cell lung
product surveillance, postmarketing
pregnancy
breast feeding
survival analysis
drug evaluation, preclinical
urinary bladder neoplasms
antibodies, monoclonal, humanized
antibodies, monoclonal
antibodies, monoclonal

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004443/human_med_002162.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
drugs, generic
Lacosamide 50mg tablet (product)
Lacosamide 100mg tablet (product)
Lacosamide 150mg tablet (product)
Lacosamide 200mg tablet (product)
tablets
treatment outcome
drug approval
acetamides
drug therapy, combination
acetamides
epilepsies, partial
adult
adolescent
administration, oral
anticonvulsants
anticonvulsants
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
lacosamide
lacosamide
lacosamide
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004303/human_med_002129.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
biosimilar pharmaceuticals
product surveillance, postmarketing
injections, intravenous
Insulin lispro 100units/mL injection solution 3mL cartridge (product)
Insulin lispro 100units/mL injection solution 3mL prefilled pen (product)
Insulin lispro 100units/mL injection solution 10mL vial (product)
insulin lispro
insulin lispro
diabetes mellitus
hypoglycemic agents
treatment outcome
drug evaluation
adult
child
injections, subcutaneous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
insulin lispro
drug evaluation
summary of product characteristics
package leaflet

---
Medikamentöse Osteoporose-therapie: Behandlungsdauer und Vorgehen nach Therapieende
https://medicalforum.ch/fr/article/doi/fms.2017.03062/
10.4414/fms.2017.03062
2017
false
false
false
Switzerland
French
German
journal article
osteoporosis, postmenopausal
diphosphonates
bisphosphonates
Denosumab
practice guidelines as topic
denosumab
bone density conservation agents
rank ligand
comparative effectiveness research
teriparatide
teriparatide
Duration of treatment (qualifier value)
osteoporotic fractures
treatment outcome
spinal fractures
guidelines for drug use
bone density
risk
vitamin D
hip fractures
rebound effect
therapy cessation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004338/human_med_002157.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
avelumab
avelumab
monoclonal antibodies
drug monitoring
product surveillance, postmarketing
treatment outcome
orphan drug production
adult
antineoplastic agents
antineoplastic agents
carcinoma, merkel cell
infusions, intravenous
antigens, CD274
neoplasm metastasis
pregnancy
breast feeding
IgG1
drug evaluation, preclinical
immunoglobulin G
antibodies, monoclonal
antibodies, monoclonal

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004390/human_med_002158.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
dupilumab
drug approval
europe
dermatitis, atopic
adult
injections, subcutaneous
Prefilled Syringe Dosage Form
self administration
treatment outcome
receptors, interleukin-13
receptors, interleukin-4
drug monitoring
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
immunoglobulin G
IgG4
drug evaluation, preclinical
antibodies, monoclonal
dupilumab
SAR231893
antibodies, monoclonal
SAR231893
SAR231893
antibodies, monoclonal

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004377/human_med_002127.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
drugs, generic
child
adolescent
Entecavir 0.5mg tablet (product)
Entecavir 1mg tablet (product)
hepatitis B, chronic
guanine
antiviral agents
administration, oral
adult
DNA-Directed DNA polymerase
drug interactions
pregnancy
breast feeding
antiviral agents
treatment outcome
drug evaluation
drug evaluation, preclinical
drug approval
entecavir
entecavir
entecavir
drug evaluation
package leaflet
summary of product characteristics

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004374/human_med_002113.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
Febuxostat
Febuxostat
drugs, generic
Febuxostat 80mg tablet (product)
drug approval
drug labeling
treatment outcome
gout suppressants
gout suppressants
hyperuricemia
xanthine oxidase
tablets
administration, oral
gout
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
febuxostat
drug evaluation
package leaflet
summary of product characteristics

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004250/human_med_002126.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
drugs, generic
anti-hiv agents
acquired immunodeficiency syndrome
reverse transcriptase inhibitors
anti-hiv agents
drug combinations
hiv infections
administration, oral
treatment outcome
reverse transcriptase inhibitors
HIV-1
adult
drug approval
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
emtricitabine, tenofovir disoproxil and efavirenz
package leaflet
drug evaluation
summary of product characteristics

---
Rekovelle - follitropin delta
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003994/human_med_002044.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
follicle stimulating hormone, human
drug approval
europe
treatment outcome
follitropin delta
infertility, female
superovulation
injections, subcutaneous
product surveillance, postmarketing
Controlled ovarian stimulation
ovarian hyperstimulation syndrome
risk assessment
breast feeding
recombinant proteins
drug evaluation, preclinical
follicle stimulating hormone, human

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004297/human_med_002059.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Tadalafil
Tadalafil
drugs, generic
Tadalafil 20mg tablet (product)
europe
adult
pregnancy
breast feeding
drug approval
treatment outcome
administration, oral
drug interactions
risk assessment
drug evaluation, preclinical
hypertension, pulmonary
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
package leaflet
summary of product characteristics
drug evaluation

---
Lusduna - insulin glargine
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004101/human_med_002058.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
insulin glargine
adult
child
diabetes mellitus
hypoglycemic agents
hypoglycemic agents
Pre-filled Pen Syringe
injections, subcutaneous
product surveillance, postmarketing
adolescent
aged
drug interactions
pregnancy
breast feeding
biosimilar pharmaceuticals
Insulin Glargine
Insulin Glargine
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device (product)

---
http://www.jle.com/fr/revues/met/e-docs/revue_pharmacologique_des_antitussifs_et_leur_place_dans_le_traitement_de_la_bronchite_aigue_virale_308992/article.phtml
DOI : 10.1684/met.2016.0611
2017
false
false
false
France
French
journal article
bronchitis
acute disease
Acute viral bronchitis (disorder)
antitussive agents
adult
child
Evidence-Based medicine
treatment outcome
antitussive agents
codeine
pholcodine
dextromethorphan
noscapine
histamine h1 antagonists
carbetapentane
ethylmorphine
france
opium alkaloids and derivatives
other cough suppressants
review of literature
bronchitis
cyclopentanes
morpholines

---
http://pharmacomedicale.org/medicaments/par-specialites/item/valproate-de-sodium-comme-regulateur-de-l-humeur
2017
false
false
false
France
French
drug information
Divalproex Sodium
mood
antimanic agents
mood, nos
valproate sodium
valproate sodium
sodium
affect
valproic acid
valproic acid

---
http://pharmacomedicale.org/medicaments/par-specialites/item/hypnotiques-les-points-essentiels
2017
false
false
false
France
French
drug information
hypnotics and sedatives
hypnotics
hypnotherapy
essential
hypnotics and sedatives

---
http://pharmacomedicale.org/medicaments/par-specialites/item/icomt
2017
false
false
false
France
French
Catechol O-Methyltransferase Inhibitors
antiparkinson agents
parkinson disease
drug information

---
http://pharmacomedicale.org/medicaments/par-specialites/item/anti-histaminiques-h2
2017
false
false
false
France
French
drug information
anti-ulcer agents
histamine h2 antagonists
histamine
histamine
histamine h2 antagonists
histamine

---
http://pharmacomedicale.org/medicaments/par-specialites/item/anti-inflammatoires-non-steroidiens
2017
false
false
false
France
French
drug information
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
inflammation, nos

---
Nitisinone 2 mg, 5 mg, and 10 mg tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00345
2017
false
false
false
Canada
French
English
summary of product characteristics
administration, oral
nitisinone
nitisinone
tablets
drug approval
canada
enzyme inhibitors
enzyme inhibitors
4-hydroxyphenylpyruvate dioxygenase
tyrosinemia, type I
nitisinone
Nitisinone (product)
treatment outcome
infant, newborn
infant
child
adolescent
risk management
product surveillance, postmarketing
adult
tyrosinemias
cyclohexanones
nitrobenzoates
cyclohexanones
nitrobenzoates

---
http://www.has-sante.fr/portail/jcms/c_2742286/fr/opdivo-cbnpc-non-epidermoide
2017
false
false
false
false
France
French
treatment outcome
nivolumab
nivolumab
infusions, intravenous
adult
aged
antineoplastic agents
programmed cell death 1 receptor
nivolumab
carcinoma, non-small-cell lung
Locally Advanced Malignant Neoplasm
neoplasm metastasis
evaluation of the transparency committee
survival analysis
Nonsquamous nonsmall cell neoplasm of lung (disorder)
antibodies, monoclonal
antibodies, monoclonal

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004048/human_med_001988.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Atazanavir Sulfate
Atazanavir Sulfate
treatment outcome
drugs, generic
Atazanavir 150mg capsule (product)
Atazanavir 200mg capsule (product)
Atazanavir 300mg capsule (product)
atazanavir
acquired immunodeficiency syndrome
anti-hiv agents
hiv protease inhibitors
anti-hiv agents
hiv protease inhibitors
hiv infections
drug therapy, combination
adult
HIV-1
drug evaluation
summary of product characteristics
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004289/human_med_002033.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Sildenafil Citrate
Sildenafil Citrate
europe
pregnancy
breast feeding
drugs, generic
Sildenafil 20mg tablet (product)
adult
drug interactions
treatment outcome
drug evaluation
3',5'-Cyclic-GMP phosphodiesterases
drug approval
administration, oral
hypertension, pulmonary
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug evaluation
summary of product characteristics
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003769/human_med_002042.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cysteamine
administration, ophthalmic
drug approval
europe
treatment outcome
orphan drug production
mercaptamine
product surveillance, postmarketing
cystinosis, ocular nonnephropathic
child
ophthalmic solutions
adult
pregnancy
breast feeding
drug evaluation, preclinical
cysteamine
cystinosis

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004140/human_med_002038.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
edotreotide
drug approval
treatment outcome
europe
radiopharmaceuticals
gastro-enteropancreatic neuroendocrine tumor
Positron-Emission tomography
adult
orphan drug production
injections, intravenous
gallium radioisotopes
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
gallium (68Ga) edotreotide
drug evaluation, preclinical
edotreotide
octreotide
intestinal neoplasms
pancreatic neoplasms
stomach neoplasms
neuroendocrine tumors

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004217/human_med_002041.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
drugs, generic
ivabradine
angina, stable
Chronic heart failure (disorder)
Ivabradine (product)
PROCORALAN 7,5 mg, comprimé pelliculé
benzazepines
pregnancy
breast feeding
treatment outcome
drug evaluation
adult
aged
benzazepines
chronic disease
ivabradine
ivabradine
drug evaluation
summary of product characteristics
package leaflet
heart failure
drug therapy, combination

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004050/human_med_002046.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
drugs, generic
Emtricitabine 200mg/tenofovir 136mg tablet (product)
pregnancy
breast feeding
drug interactions
adult
anti-hiv agents
acquired immunodeficiency syndrome
hiv infections
HIV-1
treatment outcome
drug evaluation
anti-hiv agents
drug therapy, combination
tenofovir disoproxil and emtricitabine
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004068/human_med_002030.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Darunavir
Darunavir
drugs, generic
Darunavir (product)
hiv protease inhibitors
hiv infections
hiv protease inhibitors
drug evaluation
treatment outcome
drug approval
drug labeling
tablets
administration, oral
acquired immunodeficiency syndrome
HIV-1
drug therapy, combination
drug interactions
pregnancy
breast feeding
darunavir
drug evaluation
package leaflet
summary of product characteristics

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004046/human_med_002063.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
insulin aspart
insulin aspart
drug approval
europe
treatment outcome
product surveillance, postmarketing
diabetes mellitus
injections, subcutaneous
adult
aged
infusions, intravenous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
insulin aspart

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004654/human_med_002085.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
adult
pulmonary disease, chronic obstructive
package leaflet
syndication feed
drug evaluation
summary of product characteristics
umeclidinium
umeclidinium
drug approval
europe
treatment outcome
umeclidinium bromide
administration, inhalation
muscarinic antagonists
muscarinic antagonists
drug interactions
pregnancy
breast feeding
clinical trials, phase iii as topic
drug evaluation, preclinical
GSK573719
GSK573719
quinuclidines
quinuclidines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003916/human_med_002060.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
biosimilar pharmaceuticals
europe
male osteoporosis
osteoporosis
osteoporosis
osteoporotic fractures
glucocorticoids
osteoporosis, postmenopausal
teriparatide
teriparatide
bone density conservation agents
bone density conservation agents
treatment outcome
drug approval
spinal fractures
injections, subcutaneous
drug interactions
drug evaluation, preclinical
drug storage
teriparatide
drug evaluation
summary of product characteristics
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002826/human_med_002079.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
mechlorethamine
orphan drug production
drug approval
europe
mycosis fungoides
adult
antineoplastic agents, alkylating
antineoplastic agents, alkylating
administration, cutaneous
gels
mechlorethamine hydrochloride
mechlorethamine hydrochloride
chlormethine
aged
pregnancy
breast feeding
drug evaluation, preclinical
treatment outcome
mechlorethamine

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004368/human_med_002057.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
biosimilar pharmaceuticals
male osteoporosis
europe
osteoporosis
osteoporosis
osteoporotic fractures
glucocorticoids
osteoporosis, postmenopausal
teriparatide
teriparatide
bone density conservation agents
bone density conservation agents
treatment outcome
drug approval
spinal fractures
injections, subcutaneous
drug interactions
drug evaluation, preclinical
drug storage
teriparatide
drug evaluation
summary of product characteristics
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004085/human_med_002074.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
baricitinib
drug approval
europe
baricitinib
treatment outcome
drug therapy, combination
arthritis, rheumatoid
administration, oral
adult
aged
immunosuppressive agents
immunosuppressive agents
pregnancy
breast feeding
product surveillance, postmarketing
drug interactions
janus kinase 2
janus kinase 1
drug evaluation, preclinical
baricitinib
azetidines
sulfonamides
azetidines
sulfonamides

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004167/human_med_002080.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Etanercept
Etanercept
psoriasis
Non-radiographic axial spondyloarthritis
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
arthritis, rheumatoid
arthritis, juvenile
adult
child
adolescent
antirheumatic agents
pregnancy
breast feeding
treatment outcome
drug interactions
drug evaluation, preclinical
drug approval
arthritis, psoriatic
injections, subcutaneous
drug therapy, combination
spondylitis, ankylosing
antirheumatic agents
tumor necrosis factor-alpha
etanercept
summary of product characteristics
package leaflet
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004169/human_med_002061.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tenofovir alafenamide
GS-7340
antiviral agents
antiviral agents
drug approval
europe
treatment outcome
tenofovir alafenamide
adult
adolescent
hepatitis B, chronic
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
tenofovir alafenamide
GS-7340
adenine

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004136/human_med_002062.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
antibodies, monoclonal
antibodies, monoclonal
treatment outcome
antibodies, neutralizing
antibodies, neutralizing
adult
bezlotoxumab
enterocolitis, pseudomembranous
enterocolitis, pseudomembranous
diarrhea
toxB protein, clostridium difficile
infusions, intravenous
product surveillance, postmarketing
recurrence
aged
drug interactions
pregnancy
breast feeding
bacterial proteins
bacterial toxins

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004112/human_med_002077.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Rituximab
Rituximab
biosimilar pharmaceuticals
Granulomatosis with Polyangiitis
microscopic polyangiitis
lymphoma, large B-Cell, diffuse
leukemia, lymphocytic, chronic, B-Cell
antineoplastic agents
lymphoma, follicular
treatment outcome
drug evaluation
infusions, intravenous
antigens, CD20
arthritis, rheumatoid
adult
aged
antirheumatic agents
drug interactions
pregnancy
breast feeding
antineoplastic agents
antirheumatic agents
drug therapy, combination
drug evaluation, preclinical
drug labeling
drug approval
rituximab
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004277/human_med_002075.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
Generalized anxiety disorder (disorder)
Neuropathic pain (finding)
syndication feed
Pregabalin
Pregabalin
drugs, generic
drug approval
europe
administration, oral
Pregabalin 25mg capsule (product)
Pregabalin 50mg capsule (product)
Pregabalin 75mg capsule (product)
Pregabalin 100mg capsule (product)
Pregabalin 150mg capsule (product)
Pregabalin 200mg capsule (product)
Pregabalin 225mg capsule (product)
Pregabalin 300mg capsule (product)
neuralgia
epilepsies, partial
anxiety disorders
analgesics
analgesics
anticonvulsants
anticonvulsants
treatment outcome
drug evaluation
adult
pregabalin
drug evaluation
summary of product characteristics
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004214/human_med_001662.jsp&mid=WC0b01ac058001d124
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00200
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tofacitinib
drug approval
europe
treatment outcome
tofacitinib
adult
arthritis, rheumatoid
drug therapy, combination
methotrexate
administration, oral
continuity of patient care
drug monitoring
janus kinases
pregnancy
breast feeding
drug interactions
protein kinase inhibitors
protein kinase inhibitors
product surveillance, postmarketing
aged
drug evaluation, preclinical
Tofacitinib (product)
Tofacitinib 5mg tablet (product)
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004075/human_med_002055.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
factor VIII
factor VIII
hemophilia A
hemorrhage
hemorrhage
coagulation factor VIII
Factor VIII product (product)
pregnancy
breast feeding
drug interactions
injections, intravenous
product surveillance, postmarketing
continuity of patient care
adult
child
adolescent
aged
infant
drug storage

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004164/human_med_002068.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
alectinib
administration, oral
carcinoma, non-small-cell lung
alectinib
CH5424802
protein kinase inhibitors
protein kinase inhibitors
anaplastic lymphoma kinase
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
fertility
antineoplastic agents
antineoplastic agents
drug evaluation, preclinical
alectinib
CH5424802
carbazoles
piperidines
carbazoles
piperidines
receptor Protein-Tyrosine kinases

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004016/human_med_002088.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
drugs, generic
Miglustat 100mg capsule (product)
Miglustat (product)
miglustat
gaucher disease, type 1
enzyme inhibitors
1-Deoxynojirimycin
gaucher disease
administration, oral
adult
treatment outcome
drug interactions
pregnancy
breast feeding
drug approval
miglustat
miglustat
ceramide glucosyltransferase
glucosyltransferases
1-Deoxynojirimycin
package leaflet
drug evaluation
summary of product characteristics
Gaucher disease type 1

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004666/human_med_002090.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Tadalafil
Tadalafil
benign prostatic hyperplasia
Tadalafil (product)
Tadalafil 2.5mg tablet (product)
Tadalafil 5mg tablet (product)
Tadalafil 10mg tablet (product)
Tadalafil 20mg tablet (product)
treatment outcome
drug evaluation
administration, oral
cyclic nucleotide phosphodiesterases, type 5
erectile dysfunction
drug approval
drug interactions
drug evaluation, preclinical
tadalafil
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
package leaflet
summary of product characteristics
drug evaluation
prostatic hyperplasia

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004243/human_med_002064.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
Glucagon-Like Peptide-1 Receptor
lixisenatide
drug combinations
metformin
Insulin Glargine
Insulin Glargine
Pre-filled Pen Syringe
europe
drug approval
treatment outcome
adult
diabetes mellitus, type 2
drug therapy, combination
hypoglycemic agents
hypoglycemic agents
injections, subcutaneous
drug interactions
pregnancy
breast feeding
randomized controlled trials as topic
hemoglobin A, glycosylated
blood glucose
body weight
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed
lixisenatide
lixisenatide
peptides
peptides

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004373/human_med_002076.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Adalimumab
Adalimumab
biosimilar pharmaceuticals
Axial spondyloarthritis
uveitis
Adalimumab (product)
crohn disease
colitis, ulcerative
drug labeling
drug approval
antirheumatic agents
anti-inflammatory agents
tumor necrosis factor-alpha
drug evaluation, preclinical
arthritis, rheumatoid
arthritis, psoriatic
spondylitis, ankylosing
drug interactions
pregnancy
breast feeding
antirheumatic agents
anti-inflammatory agents
adult
treatment outcome
drug evaluation
injections, subcutaneous
adalimumab
summary of product characteristics
drug evaluation
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004212/human_med_002081.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
Adalimumab
Adalimumab
biosimilar pharmaceuticals
Axial spondyloarthritis
uveitis
Adalimumab (product)
crohn disease
colitis, ulcerative
drug labeling
drug approval
antirheumatic agents
anti-inflammatory agents
tumor necrosis factor-alpha
drug evaluation, preclinical
arthritis, rheumatoid
arthritis, psoriatic
spondylitis, ankylosing
drug interactions
pregnancy
breast feeding
antirheumatic agents
anti-inflammatory agents
adult
treatment outcome
drug evaluation
injections, subcutaneous
adalimumab
summary of product characteristics
drug evaluation
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004215/human_med_002047.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
drugs, generic
Emtricitabine 200mg/tenofovir 136mg tablet (product)
Emtricitabine + tenofovir (product)
administration, oral
pregnancy
breast feeding
drug interactions
human immunodeficiency virus i infection
adult
anti-hiv agents
acquired immunodeficiency syndrome
hiv infections
HIV-1
treatment outcome
drug evaluation, preclinical
anti-hiv agents
drug therapy, combination
tenofovir disoproxil and emtricitabine
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004459/human_med_002078.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
drug evaluation
factor VIII
factor VIII
recombinant proteins
drug approval
europe
coagulation factor VIII
hemophilia A
hemorrhage
hemorrhage
injections, intravenous
summary of product characteristics
package leaflet
pregnancy
breast feeding
drug interactions
Factor VIII product (product)

---
https://www.orlfrance.org/wp-content/uploads/2017/06/AINS-et-infections-ORL-pediatriques.pdf
2017
false
false
true
France
French
practice guideline
anti-inflammatory agents, non-steroidal
otorhinolaryngologic diseases
child
pain
anti-inflammatory agents, non-steroidal
infection
infant
anti-inflammatory agents, non-steroidal
pain measurement
anti-inflammatory agents, non-steroidal
retropharyngeal abscess
otitis externa
otitis media
pharyngitis
rhinitis
sinusitis

---
http://www.has-sante.fr/portail/jcms/c_2757885/fr/opdivo-lhc
https://www.has-sante.fr/portail/jcms/c_2757885/fr/opdivo-nivolumab-anticorps-anti-pd1
2017
false
false
false
France
French
treatment outcome
nivolumab
nivolumab
infusions, intravenous
adult
antineoplastic agents
programmed cell death 1 receptor
nivolumab
evaluation of the transparency committee
survival analysis
Adult Classical Hodgkin Lymphoma
hodgkin disease
recurrence
Refractory Hodgkin Lymphoma
Recurrent Adult Hodgkin Lymphoma
guidelines for drug use
Autologous Hematopoietic Stem Cell Transplantation
hematopoietic stem cell transplantation
antibodies, monoclonal
antibodies, monoclonal

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003861/human_med_002093.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
treatment outcome
adult
hypoparathyroidism
parathyroid hormone
parathyroid hormone
product surveillance, postmarketing
chronic disease
injections, subcutaneous
aged
continuity of patient care
drug monitoring
drug interactions
pregnancy
breast feeding
parathyroid hormone
drug evaluation, preclinical

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003918/human_med_002104.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
ch14.18 monoclonal antibody
ch14.18 monoclonal antibody
antibodies, monoclonal
drug approval
europe
treatment outcome
product surveillance, postmarketing
infusions, intravenous
neuroblastoma
infant
Recurrent Neuroblastoma
dinutuximab
child
orphan drug production
drug interactions
pregnancy
breast feeding
sialogangliosides
survival analysis
drug evaluation, preclinical
antineoplastic combined chemotherapy protocols
antibodies, monoclonal
gangliosides

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004061/human_med_002019.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
chenodeoxycholic acid
chenodeoxycholic acid
chenodeoxycholic acid
adult
child
infant
orphan drug production
xanthomatosis, cerebrotendinous
Chenodiol (product)
administration, oral
product surveillance, postmarketing
adolescent
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004339/human_med_002096.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
edoxaban
edoxaban
Edoxaban Tosylate
Edoxaban Tosylate
drug approval
europe
product surveillance, postmarketing
administration, oral
stroke
embolism
adult
risk factors
atrial fibrillation
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
drug interactions
pregnancy
breast feeding
hemorrhage
Edoxaban Tosylate
hemorrhage
Factor Xa Inhibitors
Factor Xa Inhibitors
edoxaban
drug evaluation, preclinical
drug evaluation
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004310/human_med_002082.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
soft tissue infections
Bacteremia due to Staphylococcus aureus (finding)
Right-sided Staphylococcus aureus endocarditis (disorder)
syndication feed
complicated skin and soft tissue infection
antibiotic therapy
drugs, generic
adult
anti-bacterial agents
daptomycin
treatment outcome
endocarditis, bacterial
staphylococcal infections
staphylococcus aureus
bacteremia
drug compounding
daptomycin
anti-bacterial agents
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
skin diseases, infectious
drug incompatibility
drug approval
daptomycin
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003756/human_med_002083.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
methotrexate
antirheumatic agents
antirheumatic agents
dermatologic agents
dermatologic agents
psoriasis
arthritis, psoriatic
drug approval
europe
drug interactions
pregnancy
breast feeding
arthritis, rheumatoid
arthritis, juvenile
adult
adolescent
risk assessment
child
drug evaluation, preclinical
administration, oral
precursor cell lymphoblastic Leukemia-Lymphoma
antimetabolites, antineoplastic
antimetabolites, antineoplastic
methotrexate

---
https://www.has-sante.fr/portail/jcms/c_2757182/fr/rekovelle-follitropine-delta-stimulant-de-l-ovulation
https://www.has-sante.fr/portail/jcms/c_2757182/fr/rekovelle
2017
false
false
false
France
French
follicle stimulating hormone, human
treatment outcome
follitropin delta
infertility, female
superovulation
injections, subcutaneous
Controlled ovarian stimulation
recombinant proteins
evaluation of the transparency committee
guidelines for drug use
reproductive techniques, assisted
insurance, health, reimbursement
follicle stimulating hormone, human

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004196/human_med_002097.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
rolapitant
rolapitant
drug approval
europe
treatment outcome
nausea
vomiting
nausea
vomiting
antineoplastic agents
drug therapy, combination
administration, oral
Neurokinin-1 receptor antagonists
Neurokinin-1 receptor antagonists
product surveillance, postmarketing
adult
pregnancy
breast feeding
antiemetics
antiemetics
drug evaluation, preclinical
rolapitant
8-((1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4,5)decan-2-one
spiro compounds
8-((1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4,5)decan-2-one
8-((1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4,5)decan-2-one
spiro compounds
spiro compounds

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004254/human_med_002114.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
antibodies, monoclonal, humanized
sarilumab
drug approval
europe
treatment outcome
sarilumab
adult
arthritis, rheumatoid
drug therapy, combination
methotrexate
injections, subcutaneous
Prefilled Syringe Dosage Form
Pre-filled Pen Syringe
interleukin-6 receptor alpha subunit
interleukin-6 receptor alpha subunit
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
sarilumab
antibodies, monoclonal, humanized

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004065/human_med_002111.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
enzymes
recombinant proteins
TPP1 protein, human
TPP1 protein, human
product surveillance, postmarketing
orphan drug production
ceroid lipofuscinosis, neuronal, 2
infusions, intraventricular
infant, newborn
infant
child
drug monitoring
continuity of patient care
drug evaluation, preclinical
drug compounding
tripeptidyl-peptidase 1
tripeptidyl-peptidase 1
neuronal ceroid-lipofuscinoses
aminopeptidases
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
serine proteases
aminopeptidases
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
serine proteases

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004312/human_med_002119.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
orphan drug production
oligonucleotides
oligonucleotides
other nervous system drugs
product surveillance, postmarketing
spinal muscular atrophies of childhood
injections, spinal
survival of motor neuron 1 protein
survival of motor neuron 2 protein
genetic diseases, inborn
spinal muscular atrophies of childhood
child
infant
drug evaluation, preclinical
chromosomes, human, pair 5

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004246/human_med_002103.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Pentosan Polysulphate Sodium
pentosan sulfuric polyester
drug approval
europe
treatment outcome
pentosan polysulfate sodium
administration, oral
Painful Bladder Syndrome
adult
breast feeding
pregnancy
drug interactions
Pentosan Polysulphate Sodium
Elmiron
pentosan sulfuric polyester
pentosan sulfuric polyester
cystitis, interstitial

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004241/human_med_002102.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
drugs, generic
Ivabradine (product)
ivabradine
drug approval
europe
administration, oral
cardiovascular agents
cardiovascular agents
coronary artery disease
chronic heart failure
angina pectoris
benzazepines
pregnancy
breast feeding
treatment outcome
drug evaluation
adult
aged
benzazepines
chronic disease
ivabradine
ivabradine
PROCORALAN 7,5 mg, comprimé pelliculé
drug evaluation
summary of product characteristics
package leaflet
heart failure
drug therapy, combination

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004686/human_med_002091.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
French
English
syndication feed
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
drug approval
europe
drugs, generic
Emtricitabine 200mg/tenofovir 136mg tablet (product)
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
adult
anti-hiv agents
acquired immunodeficiency syndrome
hiv infections
HIV-1
treatment outcome
drug evaluation
anti-hiv agents
drug therapy, combination
tenofovir disoproxil and emtricitabine
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004019/human_med_002121.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
drugs, generic
Carglutamic acid 200mg dispersible tablet (product)
hyperammonemia
glutamates
treatment outcome
drug evaluation
carglumic acid
drug evaluation
summary of product characteristics
package leaflet
carglumic acid
glutamates
drug approval
europe
administration, oral
carglumic acid
N-acetyl glutamate synthetase deficiency
amino-acid n-acetyltransferase
urea cycle disorders, inborn
propionic acidemia
Hyperammonemia due to N-acetylglutamate synthetase deficiency

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004192/human_med_002112.jsp&mid=WC0b01ac058001d124
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00360
2017
false
Great Britain (UK)
English
French
syndication feed
Etanercept
Etanercept
biosimilar pharmaceuticals
psoriasis
Non-radiographic axial spondyloarthritis
Etanercept (product)
arthritis, rheumatoid
arthritis, juvenile
adult
chronic disease
child
adolescent
antirheumatic agents
pregnancy
breast feeding
treatment outcome
drug interactions
drug evaluation, preclinical
drug approval
arthritis, psoriatic
injections, subcutaneous
drug therapy, combination
spondylitis, ankylosing
immunologic factors
antirheumatic agents
tumor necrosis factor-alpha
etanercept
summary of product characteristics
package leaflet
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004488/human_med_002094.jsp&mid=WC0b01ac058001d124
2017
false
Great Britain (UK)
English
French
syndication feed
drugs, generic
Pemetrexed
Pemetrexed
Pemetrexed (product)
antimetabolites, antineoplastic
antineoplastic agents
folic acid antagonists
mesothelioma
carcinoma, non-small-cell lung
thymidylate synthase
treatment outcome
drug approval
infusions, intravenous
pleural neoplasms
continuity of patient care
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pemetrexed
package leaflet
summary of product characteristics
drug evaluation

---
https://www.has-sante.fr/portail/jcms/c_2788656/fr/somakit-toc
https://www.has-sante.fr/portail/jcms/c_2788656/fr/somakit-toc-68ga-edotreotide-radiopharmaceutique-a-usage-diagnostique
2017
false
false
false
France
French
edotreotide
radiopharmaceuticals
gastro-enteropancreatic neuroendocrine tumor
Positron-Emission tomography
adult
orphan drug production
injections, intravenous
gallium radioisotopes
aged
gallium (68Ga) edotreotide
evaluation of the transparency committee
receptors, somatostatin
neoplasm metastasis
Gallium Ga 68-Edotreotide
guidelines for drug use
edotreotide
octreotide
intestinal neoplasms
pancreatic neoplasms
stomach neoplasms
neuroendocrine tumors

---
Oxervate cenegermin
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004209/human_med_002135.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
nerve growth factor
orphan drug production
Neurotrophic keratopathy
keratitis
adult
ophthalmic solutions
administration, ophthalmic
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
recombinant proteins
recombinant proteins

---
Besponsa - inotuzumab ozogamicin
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004119/human_med_002109.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
drug approval
europe
treatment outcome
inotuzumab ozogamicin
inotuzumab ozogamicin
Adult B Acute Lymphoblastic Leukemia
antineoplastic agents
antineoplastic agents
precursor b-cell lymphoblastic leukemia-lymphoma
adult
sialic acid binding ig-like lectin 2
precursor b-cell lymphoblastic leukemia-lymphoma
precursor b-cell lymphoblastic leukemia-lymphoma
sialic acid binding ig-like lectin 2
CD22 protein, human
CD22 protein, human
infusions, intravenous
antibodies, monoclonal, humanized
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug compounding
inotuzumab ozogamicin
antibodies, monoclonal, humanized

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002157/human_med_002118.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Dimethyl Fumarate
drug approval
europe
treatment outcome
psoriasis
dermatologic agents
dermatologic agents
administration, oral
tablets
immunosuppressive agents
immunosuppressive agents
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
antipsoriatics for systemic use
Dimethyl Fumarate

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004197/human_med_002100.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
product surveillance, postmarketing
drug approval
europe
fluciclovine (18F)
radiopharmaceuticals
prostatic neoplasms
neoplasm recurrence, local
Recurrent Prostate Cancer
fluciclovine F-18
injections, intravenous
Positron-Emission tomography
adult
aged
drug evaluation, preclinical
fluciclovine F-18
carboxylic acids
cyclobutanes
carboxylic acids
cyclobutanes

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004257/human_med_002139.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
Adrenergics in combination with anticholinergics
drug approval
europe
drug combinations
treatment outcome
Formoterol Fumarate
Beclomethasone Dipropionate
Beclomethasone Dipropionate
beclomethasone
glycopyrrolate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
glucocorticoids
aged
drug interactions
pregnancy
breast feeding
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
muscarinic antagonists
muscarinic antagonists
exacerbation of chronic obstructive bronchitis
forced expiratory volume
drug evaluation, preclinical
glycopyrrolate
beclomethasone
Formoterol Fumarate

---
http://pharmacomedicale.org/medicaments/par-specialites/item/benzamides
2016
false
false
false
France
French
benzamides
antipsychotic agents
psychotic disorders
drug information
benzamides

---
http://pharmacomedicale.org/medicaments/par-specialites/item/aripiprazole
2016
false
false
false
France
French
drug information
Aripiprazole
antipsychotic agents
psychotic disorders
Aripiprazole

---
http://pharmacomedicale.org/medicaments/par-specialites/item/clozapine
2016
false
false
false
France
French
drug information
clozapine
antipsychotic agents
psychotic disorders
clozapine
clozapine
clozapine

---
http://pharmacomedicale.org/medicaments/par-specialites/item/olanzapine
2016
false
false
false
France
French
drug information
antipsychotic agents
psychotic disorders
olanzapine
olanzapine
benzodiazepines
benzodiazepines

---
http://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-de-la-pompe-a-proton
2016
false
false
false
France
French
drug information
anti-ulcer agents
proton pump inhibitors
proton pump inhibitors
pump, nos
proton

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antiacides-et-pansements-digestifs
2016
false
false
false
France
French
drug information
antacids
anti-ulcer agents
sucralfate
dressings
digestant, nos
digestants
digestion
digestive tract function, nos
antacids
digestive system, nos
bandages
gastrointestinal agents

---
http://pharmacomedicale.org/medicaments/par-specialites/item/analogues-pge1-misoprostol
2016
false
false
false
France
French
drug information
misoprostol
anti-ulcer agents
prostaglandins E
misoprostol
misoprostol
alprostadil

---
http://pharmacomedicale.org/medicaments/par-specialites/item/paracetamol
2016
false
false
false
France
French
drug information
analgesics, non-narcotic
acetaminophen

---
http://pharmacomedicale.org/medicaments/par-specialites/item/aspirine
2016
false
false
false
France
French
drug information
aspirin
anti-inflammatory agents, non-steroidal
cyclooxygenase inhibitors
acetylsalicylic acid
aspirin

---
http://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-de-reverse-transcriptase-du-vih
2016
false
false
false
France
French
drug information
reverse transcriptase inhibitors
anti-hiv agents
hiv infections
HIV
reverse transcriptase inhibitors
human immunodeficiency virus, nos

---
http://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-de-la-protease-du-vih
2016
false
false
false
France
French
drug information
hiv protease inhibitors
hiv infections
human immunodeficiency virus, nos
hiv protease inhibitors

---
http://pharmacomedicale.org/medicaments/par-specialites/item/autres-antiretroviraux
2016
false
false
false
France
French
drug information
hiv fusion inhibitors
enfuvirtide
hiv infections
enfuvirtide
maraviroc
maraviroc
CCR5 Receptor Antagonists
Raltegravir Potassium
raltegravir
HIV integrase inhibitors
anti-retroviral agents
peptide fragments
HIV envelope protein gp41
cyclohexanes
triazoles

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antiviraux-utilises-dans-les-hepatites-virales
2016
false
false
false
France
French
drug information
protease inhibitors
antiviral agents
nucleic acid synthesis inhibitors
interferon-alpha
Pegylated Interferon Alfa
hepatitis B
hepatitis C
viral hepatitis
hepatitis, viral, human
antiviral agents
hepatitis
viral hepatitis, nos
hepatitis

---
http://pharmacomedicale.org/medicaments/par-specialites/item/anti-herpesviridae-acilovir-famciclovir-ganciclovir-foscarnet-docosanol
2016
false
false
false
France
French
drug information
antiviral agents
herpesviridae infections
famciclovir
famciclovir
foscarnet
docosanol
herpesviridae
foscarnet
ganciclovir
ganciclovir
2-Aminopurine
fatty alcohols

---
http://pharmacomedicale.org/medicaments/par-specialites/item/beta-bloquants?category_id=6
2016
false
false
false
France
French
drug information
adrenergic beta-antagonists
angina, stable
angina, stable
hypertension
beta, nos
obstruction, nos
blocking
adrenergic beta-antagonists

---
http://pharmacomedicale.org/medicaments/par-specialites/item/meprobamate
2016
false
false
false
France
French
drug information
meprobamate
anti-anxiety agents
hypnotics and sedatives
muscle relaxants, central
contracture
anxiety disorders
meprobamate
meprobamate
bipiperidyl mustard
meprobamate
mustard compounds

---
http://pharmacomedicale.org/medicaments/par-specialites/item/buspirone
2016
false
false
false
France
French
drug information
buspirone
anti-anxiety agents
buspirone
serotonin 5-HT1 receptor agonists
anxiety disorders
Generalized Anxiety Disorder
buspirone
buspirone

---
http://pharmacomedicale.org/medicaments/par-specialites/item/benzodiazepines
2016
false
false
false
France
French
drug information
benzodiazepines
anti-anxiety agents
anxiety disorders
sleep initiation and maintenance disorders
GABA modulators
benzodiazepine derivatives

---
http://pharmacomedicale.org/medicaments/par-specialites/item/beta-2-stimulants-a-courte-et-longue-duree-d-action
2016
false
false
false
France
French
drug information
anti-asthmatic agents
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
asthma
selective beta-2-adrenoreceptor agonists

---
http://pharmacomedicale.org/medicaments/par-specialites/item/42
2016
false
false
false
France
French
drug information
anti-asthmatic agents
glucocorticoids
administration, inhalation
asthma
persistent asthma
glucocorticoids

---
http://www.jle.com/fr/revues/med/e-docs/strategies_de_prescription_des_antipsychotiques_dans_la_schizophrenie_une_revue_actualisee_307439/article.phtml
10.1684/med.2016.60
2016
false
false
false
France
French
journal article
schizophrenia
antipsychotic agents
drug prescriptions
drug therapy, combination
administration, oral
review of literature
Dopamine D2 Receptor Antagonists
antipsychotic agents
injections, intramuscular
Delayed-Action preparations
serotonin 5-HT2 receptor antagonists
serotonin 5-HT2A receptor antagonists
serotonin uptake inhibitors
drug interactions
treatment outcome
antipsychotic agents
antipsychotics

---
https://www.revmed.ch/RMS/2016/RMS-N-530/Potassium-et-pression-arterielle-une-vieille-histoire-revisitee
2016
false
false
false
Switzerland
French
journal article
hypertension
potassium
potassium deficiency
Potassium supplementation
potassium, dietary
sodium
cardiovascular diseases
hypertension
potassium
Potassium increased diet (finding)
arterial pressure
sodium chloride, dietary
High potassium food (substance)

---
http://www.has-sante.fr/portail/jcms/c_2613503/fr/klean-prep
http://www.has-sante.fr/portail/jcms/c_962481/klean-prep
2016
false
France
French
bowel preparation solutions
colonic diseases
colonic diseases
drug combinations
macrogol, combinations
administration, oral
insurance, health, reimbursement
polyethylene glycols
sodium sulfate
sodium bicarbonate
potassium chloride
sodium chloride
cathartics
sulfates
polyethylene glycol 3350
evaluation of the transparency committee
cathartics

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002709/human_med_001719.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500155417
2016
false
Great Britain (UK)
English
French
aminosalicylic acid
aminosalicylic acid
drug approval
europe
treatment outcome
aminosalicylic acid
adult
child
infant
adolescent
drug therapy, combination
tuberculosis, multidrug-resistant
antitubercular agents
antitubercular agents
drug interactions
mycobacterium tuberculosis
orphan drug production
summary of product characteristics
package leaflet
drug evaluation
syndication feed
pregnancy
breast feeding
Aminosalicylic acid (product)
administration, oral
antibiotic therapy

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004126/human_med_002001.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
grazoprevir
grazoprevir
elbasvir
elbasvir
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
adult
hepatitis C, chronic
antiviral agents
viral vaccines
Hepatitis C virus subtype 1a (organism)
Hepatitis C virus subtype 1b (organism)
Hepatitis C virus genotype 4 (organism)
administration, oral
drug antagonism
drug evaluation, preclinical
NS-5a protein, hepatitis C virus
protease inhibitors
protease inhibitors
NS3 protein, hepatitis C virus
NS4A cofactor peptide, hepatitis C virus
drug therapy, combination
elbasvir and grazoprevir
elbasvir-grazoprevir drug combination
NS-5 protein, hepatitis C virus
quinoxalines
quinoxalines
benzofurans
imidazoles
viral nonstructural proteins
carrier proteins
benzofurans
imidazoles
benzofurans
imidazoles
quinoxalines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004210/human_med_001997.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
velpatasvir
velpatasvir
drug combinations
direct acting antivirals
Sofosbuvir
Sofosbuvir
antiviral agents
antiviral agents
pregnancy
breast feeding
drug interactions
hepatitis C, chronic
adult
administration, oral
drug therapy, combination
NS-5a protein, hepatitis C virus
enzyme inhibitors
enzyme inhibitors
RNA replicase
product surveillance, postmarketing
aged
drug evaluation, preclinical
sofosbuvir-velpatasvir drug combination
NS-5 protein, hepatitis C virus
viral nonstructural proteins
carbamates
Heterocyclic Compounds, 4 or More Rings
carbamates
Heterocyclic Compounds, 4 or More Rings
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004057/human_med_002000.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
dapagliflozin
dapagliflozin
saxagliptin and dapagliflozin
saxagliptin
saxagliptin
adult
diabetes mellitus, type 2
administration, oral
Sodium-Glucose transporter 2
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
glucosides
benzhydryl compounds
glucosides
benzhydryl compounds
dipeptides
adamantane
adamantane
dipeptides
adamantane

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003895/human_med_001999.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
English
French
syndication feed
Nonsquamous nonsmall cell neoplasm of lung (disorder)
folic acid antagonists
Pemetrexed 500mg powder injection solution vial (product)
Pemetrexed 100mg powder for injection solution vial (product)
Pleural Malignant Mesothelioma
drugs, generic
Pemetrexed
Pemetrexed
antimetabolites, antineoplastic
antineoplastic agents
folic acid antagonists
mesothelioma
carcinoma, non-small-cell lung
thymidylate synthase
treatment outcome
drug approval
drug evaluation
infusions, intravenous
pleural neoplasms
continuity of patient care
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pemetrexed
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004076/human_med_001996.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
English
French
syndication feed
Bortezomib
Bortezomib
drug approval
europe
pregnancy
breast feeding
drug interactions
drugs, generic
drug therapy, combination
lymphoma, mantle-cell
antineoplastic agents
proteasome inhibitors
proteasome inhibitors
injections, intravenous
Bortezomib 3.5mg lyophilized powder for injection (product)
adult
drug evaluation, preclinical
antineoplastic agents
multiple myeloma
treatment outcome
bortezomib
drug evaluation
summary of product characteristics
package leaflet

---
www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004207/human_med_001995.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
English
French
syndication feed
Bortezomib
Bortezomib
drug approval
europe
pregnancy
breast feeding
drug interactions
drugs, generic
drug therapy, combination
lymphoma, mantle-cell
antineoplastic agents
proteasome inhibitors
proteasome inhibitors
injections, intravenous
Bortezomib 3.5mg lyophilized powder for injection (product)
adult
drug evaluation, preclinical
antineoplastic agents
multiple myeloma
treatment outcome
bortezomib
drug evaluation
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/jcms/c_2635757/fr/praxbind-idarucizumab-antidote-du-dabigatran
2016
false
false
false
France
French
idarucizumab
idarucizumab
Anticoagulant reversal therapy
anticoagulants
emergency treatment
hemorrhage
surgical procedures, operative
hemorrhage
hemorrhage
adult
treatment outcome
injections, intravenous
infusions, intravenous
idarucizumab
Dabigatran
evaluation of the transparency committee
guidelines for drug use
antidotes
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
pyridines

---
Summary Basis of Decision (SBD) for Cinqair
Reslizumab, 10 mg/mL, solution, intravenous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?linkID=SBD00331
2016
false
false
false
Canada
French
English
summary of product characteristics
reslizumab
reslizumab
reslizumab
canada
pharmaceutical solutions
risk assessment
Interleukin-5
adult
asthma
Eosinophilic asthma
eosinophilia
receptors, interleukin-5
treatment outcome
product surveillance, postmarketing
IgG4
drug evaluation
infusions, intravenous
immunoglobulin G
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized

---
http://www.has-sante.fr/portail/jcms/c_2678850/fr/taltz
http://www.has-sante.fr/portail/jcms/c_2678850/fr/taltz-ixekizumab-immunosuppresseur-inhibiteur-de-l-interleukine-il-17a
2016
false
false
false
France
French
ixekizumab
antibodies, monoclonal, humanized
psoriasis
treatment outcome
adult
injections, subcutaneous
Interleukin-17
Interleukin-17A
Interleukin-17
Interleukin-17A
evaluation of the transparency committee
insurance, health, reimbursement
chronic disease
ixekizumab
guidelines for drug use
ixekizumab
antibodies, monoclonal, humanized

---
http://www.has-sante.fr/portail/jcms/c_2682094/fr/opdivo-carcinome-a-cellules-renales
2016
false
false
false
France
French
treatment outcome
nivolumab
nivolumab
infusions, intravenous
adult
antineoplastic agents
programmed cell death 1 receptor
nivolumab
Locally Advanced Malignant Neoplasm
evaluation of the transparency committee
survival analysis
carcinoma, renal cell
clear cell renal cell carcinoma
Clear Cell Neoplasm
antibodies, monoclonal
antibodies, monoclonal

---
Summary Basis of Decision (SBD) for Alecensaro
Alectinib (as alectinib hydrochloride), 150 mg, capsule, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00332
2016
false
false
false
Canada
French
English
administration, oral
treatment outcome
alectinib
alectinib
drug approval
canada
risk assessment
protein kinase inhibitors
protein kinase inhibitors
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
mutation
Locally Advanced Malignant Neoplasm
neoplasm metastasis
anaplastic lymphoma kinase
disease progression
product surveillance, postmarketing
alectinib
Alectinib hydrochloride (substance)
drug information
CH5424802
CH5424802
carbazoles
piperidines
carbazoles
piperidines
receptor Protein-Tyrosine kinases

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004098/human_med_002025.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
eluxadoline
imidazoles
drug approval
europe
gastrointestinal agents
gastrointestinal agents
product surveillance, postmarketing
adult
irritable bowel syndrome
diarrhea
administration, oral
tablets
risk assessment
Irritable bowel syndrome with diarrhea (disorder)
aged
drug interactions
pregnancy
breast feeding
receptors, opioid, delta
receptors, opioid, mu
receptors, opioid, kappa
eluxadoline
eluxadoline
imidazoles
phenylalanine

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003883/human_med_001992.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
glycopyrrolate
drug approval
europe
glycopyrronium
child
adolescent
drug interactions
sialorrhea
administration, oral
pharmaceutical solutions
nervous system diseases
muscarinic antagonists
muscarinic antagonists
risk assessment
chronic disease
drug evaluation, preclinical
glycopyrrolate

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003983/human_med_002015.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
methotrexate
antirheumatic agents
antirheumatic agents
dermatologic agents
dermatologic agents
psoriasis
arthritis, psoriatic
drug approval
europe
drug interactions
pregnancy
breast feeding
arthritis, rheumatoid
arthritis, juvenile
adult
adolescent
injections, subcutaneous
risk assessment
Pre-filled Pen Syringe
child
drug evaluation, preclinical
methotrexate

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004267/human_med_002008.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate
Fluticasone Propionate
drug approval
europe
drug interactions
pregnancy
breast feeding
salmeterol and fluticasone
pulmonary disease, chronic obstructive
asthma
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
Severe asthma (disorder)
adult
administration, inhalation
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
risk assessment
drug evaluation, preclinical
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone
Fluticasone

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003912/human_med_002012.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
antibodies, monoclonal, humanized
reslizumab
reslizumab
drug approval
europe
drug interactions
pregnancy
breast feeding
asthma
eosinophilia
adult
Eosinophilic asthma
infusions, intravenous
Interleukin-5
Interleukin-5
risk assessment
product surveillance, postmarketing
drug therapy, combination
aged
continuity of patient care
reslizumab
antibodies, monoclonal, humanized

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003795/human_med_002024.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
enoxaparin
drug approval
europe
enoxaparin
breast feeding
pregnancy
drug interactions
injections, subcutaneous
injections, intravenous
Prefilled Syringe Dosage Form
biosimilar pharmaceuticals
anticoagulants
anticoagulants
drug therapy, combination
aspirin
angina, unstable
myocardial infarction
venous thromboembolism
postoperative complications
deep vein thrombosis
clotting in the extracorporeal circuit during haemodialysis
catheter obstruction
fibrinolytic agents
fibrinolytic agents
adult
risk assessment
product surveillance, postmarketing
drug evaluation, preclinical
Factor Xa Inhibitors
Factor Xa Inhibitors
enoxaparin
venous thrombosis

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004125/human_med_002022.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
irinotecan
irinotecan
drug approval
europe
drug interactions
pregnancy
breast feeding
adult
neoplasm metastasis
pancreatic neoplasms
adenocarcinoma
Pancreatic adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
antineoplastic combined chemotherapy protocols
risk assessment
antineoplastic agents, phytogenic
antineoplastic agents, phytogenic
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
drug evaluation, preclinical
irinotecan
camptothecin

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004163/human_med_002018.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cabozantinib
anilides
pyridines
cabozantinib
drug approval
europe
drug interactions
pregnancy
breast feeding
carcinoma, renal cell
Advanced Malignant Neoplasm
Cabozantinib S-malate
receptor Protein-Tyrosine kinases
administration, oral
tablets
adult
protein kinase inhibitors
protein kinase inhibitors
risk assessment
product surveillance, postmarketing
survival analysis
drug evaluation, preclinical
cabozantinib
anilides
pyridines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002752/human_med_002007.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate
Fluticasone Propionate
drug approval
europe
drug interactions
pregnancy
breast feeding
salmeterol and fluticasone
pulmonary disease, chronic obstructive
asthma
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
Severe asthma (disorder)
adult
administration, inhalation
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
risk assessment
drug evaluation, preclinical
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone
Fluticasone

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69043954
2016
false
false
false
France
French
summary of product characteristics
package leaflet
drug combinations
administration, intranasal
nasal sprays
histamine H1 antagonists, non-sedating
anti-inflammatory agents
Fluticasone Propionate
azelastine hydrochloride
fluticasone, combinations
rhinitis, allergic, seasonal
rhinitis, allergic, perennial
drug interactions
pregnancy
breast feeding
Fluticasone Propionate
azelastine hydrochloride
drug evaluation, preclinical
anti-inflammatory agents
histamine H1 antagonists, non-sedating
anti-allergic agents
anti-allergic agents
Fluticasone
suspension, nos
azelastine
propionate
azelastine hydrochloride
nose, nos
Fluticasone Propionate
propionates
suspensions
azelastine hydrochloride
Fluticasone
azelastine
Fluticasone
azelastine
phthalazines
phthalazines
phthalazines

---
BRENZYS Summary Basis of Decision (SBD)
Etanercept 50 mg/mL solution, subcutaneous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00333
2016
false
false
false
Canada
French
English
summary of product characteristics
canada
drug evaluation
drug approval
Etanercept
Etanercept
etanercept
Pre-filled Pen Syringe
Prefilled Syringe Dosage Form
adult
arthritis, rheumatoid
spondylitis, ankylosing
tumor necrosis factor-alpha
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
immunologic factors
immunologic factors
antirheumatic agents
antirheumatic agents
Etanercept (product)
product surveillance, postmarketing
treatment outcome

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003853/human_med_002034.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
palbociclib
palbociclib
drug approval
europe
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
breast neoplasms
neoplasm metastasis
Locally Advanced Malignant Neoplasm
antineoplastic combined chemotherapy protocols
Hormone receptor positive malignant neoplasm of breast (disorder)
administration, oral
Cyclin-Dependent kinase 4
Cyclin-Dependent kinase 6
survival analysis
Progression-Free survival
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Human epidermal growth factor 2 negative carcinoma of breast (disorder)
palbociclib
piperazines
pyridines
disease-free survival
piperazines
pyridines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003995/human_med_002037.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
hyperparathyroidism, secondary
adult
injections, intravenous
hemodialysis
calcimimetic agents
calcimimetic agents
parathyroid hormone
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
renal insufficiency, chronic
peptides
peptides
drug evaluation, preclinical
etelcalcetide
renal dialysis

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003833/human_med_002032.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
Linagliptin
empagliflozin
drug approval
europe
treatment outcome
pregnancy
breast feeding
hypoglycemic agents
hypoglycemic agents
adult
diabetes mellitus, type 2
product surveillance, postmarketing
linagliptin and empagliflozin
administration, oral
Sodium-Glucose transporter 2
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
drug evaluation, preclinical
Empagliflozin + linagliptin (product)
Linagliptin
empagliflozin
benzhydryl compounds
glucosides
benzhydryl compounds
glucosides

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004216/human_med_002036.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
antibodies, monoclonal
olaratumab
drug approval
europe
treatment outcome
drug interactions
pregnancy
breast feeding
orphan drug production
antineoplastic agents
antineoplastic agents
adult
sarcoma
antineoplastic combined chemotherapy protocols
receptor, platelet-derived growth factor alpha
survival analysis
monoclonal antibodies
infusions, intravenous
product surveillance, postmarketing
drug evaluation, preclinical
olaratumab
antibodies, monoclonal

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004224/human_med_002021.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
lenvatinib
drug approval
europe
treatment outcome
drug interactions
antineoplastic combined chemotherapy protocols
carcinoma, renal cell
adult
protein kinase inhibitors
protein kinase inhibitors
antineoplastic agents
antineoplastic agents
lenvatinib
administration, oral
protein-tyrosine kinases
product surveillance, postmarketing
pregnancy
breast feeding
receptor Protein-Tyrosine kinases
drug evaluation, preclinical
lenvatinib
phenylurea compounds
quinolines
phenylurea compounds
quinolines
phenylurea compounds
quinolines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004137/human_med_002031.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
French
English
syndication feed
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
drugs, generic
human immunodeficiency virus i infection
drug approval
europe
pregnancy
breast feeding
drug interactions
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
adult
anti-hiv agents
acquired immunodeficiency syndrome
hiv infections
HIV-1
treatment outcome
drug evaluation
anti-hiv agents
drug therapy, combination
tenofovir disoproxil and emtricitabine
package leaflet
summary of product characteristics

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004106/human_med_002045.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
venetoclax
venetoclax
leukemia, lymphocytic, chronic, B-Cell
drug approval
europe
risk assessment
pregnancy
breast feeding
drug interactions
administration, oral
B-Cell leukemia 2 family proteins
antineoplastic agents
antineoplastic agents
leukemia, lymphocytic, chronic, B-Cell
Loss of Chromosome 17p
genes, p53
product surveillance, postmarketing
mutation
continuity of patient care
drug monitoring
adult
aged
drug evaluation, preclinical
Response Rate
venetoclax
venetoclax
venetoclax
Proto-Oncogene proteins c-bcl-2
sulfonamides
bicyclo compounds, heterocyclic
sulfonamides
bicyclo compounds, heterocyclic

---
obeticholic acid
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004093/human_med_002043.jsp&mid=WC0b01ac058001d124
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00357
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
drug approval
europe
cholangitis
Primary cholangitis (disorder)
obeticholic acid
obeticholic acid
obeticholic acid
adult
drug therapy, combination
ursodeoxycholic acid
administration, oral
risk assessment
pregnancy
breast feeding
drug interactions
product surveillance, postmarketing
drug evaluation, preclinical
chenodeoxycholic acid
chenodeoxycholic acid
chenodeoxycholic acid

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003844/human_med_001998.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
ixazomib
ixazomib
ixazomib
drug approval
europe
orphan drug production
adult
multiple myeloma
antineoplastic combined chemotherapy protocols
antineoplastic agents
antineoplastic agents
administration, oral
proteasome inhibitors
proteasome inhibitors
risk assessment
product surveillance, postmarketing
drug monitoring
dexamethasone
lenalidomide
continuity of patient care
drug interactions
pregnancy
breast feeding
survival analysis
aged
drug evaluation, preclinical
boron compounds
glycine
glycine
boron compounds
glycine
thalidomide
thalidomide

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004049/human_med_002048.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
French
English
syndication feed
Tenofovir
Tenofovir
drugs, generic
drug approval
europe
breast feeding
drug interactions
Tenofovir 245mg tablet (product)
administration, oral
drug therapy, combination
human immunodeficiency virus i infection
drug evaluation, preclinical
treatment outcome
drug evaluation
adult
HIV-1
hiv infections
acquired immunodeficiency syndrome
reverse transcriptase inhibitors
anti-hiv agents
anti-hiv agents
reverse transcriptase inhibitors
pregnancy
tenofovir disoproxil
package leaflet
summary of product characteristics

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004186/human_med_002027.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
English
French
syndication feed
Sildenafil Citrate
Sildenafil Citrate
europe
pregnancy
breast feeding
child
drugs, generic
adolescent
Sildenafil 20mg tablet (product)
adult
drug interactions
treatment outcome
drug evaluation
3',5'-Cyclic-GMP phosphodiesterases
drug approval
administration, oral
hypertension, pulmonary
phosphodiesterase 5 inhibitors
phosphodiesterase 5 inhibitors
drug evaluation
summary of product characteristics
package leaflet

---
ADYNOVATE - Summary Basis of Decision (SBD)
Antihemophilic Factor VIII (Recombinant), PEGylated
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00340
2016
false
false
false
Canada
French
English
drug evaluation
factor VIII
factor VIII
recombinant proteins
recombinant proteins
drug approval
canada
hemorrhage
hemorrhage
intraoperative care
hemophilia A
polyethylene glycols
treatment outcome
summary of product characteristics
coagulation factor VIII
injections, intravenous
BAX 855
BAX 855

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antiasthmatiques-les-points-essentiels
2016
false
false
false
France
French
drug information
anti-asthmatic agents
pharmacology
anti-asthmatic agents
essential

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antibiotiques-les-points-essentiels
2016
false
false
false
France
French
anti-bacterial agents
pharmacology
drug information
antibiotic, nos
essential
antibiotics
anti-bacterial agents

---
http://pharmacomedicale.org/medicaments/par-specialites/item/medicaments-inducteurs-de-l-ovulation
2016
false
false
false
France
French
drug information
fertility agents
ovulation
ovulation
drug, nos
pharmaceutical preparations

---
http://pharmacomedicale.org/medicaments/par-specialites/item/anticancereux-les-points-essentiels
2016
false
false
false
France
French
drug information
antineoplastic agents
essential
antineoplastic agents

---
http://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-d-enzymes-liees-a-l-adn
2016
false
false
false
France
French
drug information
antineoplastic agents
enzyme inhibitors
DNA
enzyme, nos
deoxyribonucleic acid, nos
enzymes
enzymes

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antimetabolites
2016
false
false
false
France
French
drug information
antimetabolites, antineoplastic
antimetabolite, nos
antimetabolites

---
http://pharmacomedicale.org/medicaments/par-specialites/item/alkylants
2016
false
false
false
France
French
drug information
antineoplastic agents, alkylating
alkylation
alkylating agents
alkylation

---
http://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-de-proteines-kinases
2016
false
false
false
France
French
protein kinase inhibitors
drug information
protein kinase inhibitors
protein kinase

---
http://pharmacomedicale.org/medicaments/par-specialites/item/inhibiteurs-de-l-aromatase
2016
false
false
false
France
French
aromatase inhibitors
drug information
aromatase inhibitors

---
http://pharmacomedicale.org/medicaments/par-specialites/item/hemostase-les-points-essentiels
2016
false
false
false
France
French
drug information
fibrinolytic agents
anticoagulants
platelet aggregation inhibitors
hemostasis
essential
hemostatic function, nos

---
http://pharmacomedicale.org/medicaments/par-specialites/item/les-agents-antiplaquettaires
2016
false
false
false
France
French
drug information
platelet aggregation inhibitors
antiplatelet agents
platelet aggregation inhibitors

---
http://pharmacomedicale.org/medicaments/par-specialites/item/anticoagulants-heparines-et-derives
2016
false
false
false
France
French
drug information
anticoagulants
heparin
fondaparinux
danaparoid
hirudins
antithrombins
anticoagulants
heparin
shunt, nos
anticoagulant, nos
heparin
danaproid
dermatan sulfate
heparitin sulfate
chondroitin sulfates
polysaccharides

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antagonistes-de-la-vitamine-k-avk
2016
false
false
false
France
French
antivitamins K
drug information
anticoagulants
vitamin K
antivitamins K
vitamin k, nos
indenes
4-hydroxycoumarins
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
http://pharmacomedicale.org/medicaments/par-specialites/item/anticoagulants-oraux-directs-aods
2016
false
false
false
France
French
anticoagulants
administration, oral
drug information
anticoagulant, nos
guideline
anticoagulants
guideline

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antidiabetiques-les-points-essentiels
2016
false
false
false
France
French
drug information
hypoglycemic agents
essential
antidiabetics
hypoglycemic agents

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antidepresseurs-les-points-essentiels
2016
false
false
false
France
French
drug information
antidepressive agents
antidepressant, nos
essential
antidepressive agents

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antidiarrheiques-les-points-essentiels
2016
false
false
false
France
French
antidiarrheals
drug information
essential
antidiarrheals

---
http://pharmacomedicale.org/medicaments/par-specialites/item/immunosuppresseurs-les-points-essentiels
2016
false
false
false
France
French
drug information
immunosuppressive agents
immunosuppressive agents
essential

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antiemetiques-les-points-essentiels
2016
false
false
false
France
French
drug information
antiemetics
essential
antiemetics
antiemetic, nos

---
http://pharmacomedicale.org/medicaments/par-specialites/item/medicaments-de-la-constipation
2016
false
false
false
France
French
drug information
constipation
cathartics
laxatives
constipation
pharmaceutical preparations
constipation
constipation
drug, nos

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antifungiques-les-points-essentiels
2016
false
false
false
France
French
drug information
antifungal agents
antifungal agents
essential

---
http://pharmacomedicale.org/medicaments/par-specialites/item/medicaments-de-la-plaque-neuromusculaire-les-points-essentiels
2016
false
false
false
France
French
drug information
cholinesterase inhibitors
neuromuscular blocking agents
botulinum antitoxin
drug, nos
myoneural junction
neuromuscular junction
essential
drugs, essential

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antigoutteux-les-points-essentiels
2016
false
false
false
France
French
drug information
gout suppressants
gout suppressants
essential

---
http://pharmacomedicale.org/medicaments/par-specialites/item/opiacees-les-points-essentiels
2016
false
false
false
France
French
drug information
analgesics, opioid
essential

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antimigraineux-points-essentiels
2016
false
false
false
France
French
migraine disorders
Agent for migraine (substance)
drug information
essential

---
http://pharmacomedicale.org/medicaments/par-specialites/item/regulateurs-de-l-humeur-thymoregulateurs-les-points-essentiels
2016
false
false
false
France
French
drug information
antimanic agents
essential
mood
antimanic agents
mood, nos
affect

---
http://pharmacomedicale.org/medicaments/par-specialites/item/antipaludeens-les-points-essentiels
2016
false
false
false
France
French
drug information
antimalarials
essential
antimalarials

---
http://pharmacomedicale.org/medicaments/par-specialites/item/phenothiazines
2016
false
false
false
France
French
drug information
antipsychotic agents
phenothiazines
psychotic disorders
phenothiazine
phenothiazine, nos
phenothiazines

---
http://pharmacomedicale.org/medicaments/par-specialites/item/loxapine
2016
false
false
false
France
French
drug information
loxapine
antipsychotic agents
psychotic disorders
loxapine
loxapine

---
http://pharmacomedicale.org/medicaments/par-specialites/item/butyrophenones
2016
false
false
false
France
French
drug information
butyrophenones
antipsychotic agents
psychotic disorders
butyrophenones

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000539/human_med_001130.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500019839
2016
false
Great Britain (UK)
English
French
syndication feed
Bortezomib
Bortezomib
drug approval
europe
pregnancy
breast feeding
drug interactions
drug therapy, combination
adult
drug evaluation, preclinical
lymphoma, mantle-cell
injections, intravenous
antineoplastic agents
proteasome inhibitors
proteasome inhibitors
antineoplastic agents
multiple myeloma
treatment outcome
bortezomib
drug evaluation
summary of product characteristics
package leaflet

---
http://www.extenso.org/article/le-curcuma-combat-le-cancer/
2016
false
false
Canada
French
curcuma
neoplasms
curcumin
antineoplastic agents
popular works

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002835/human_med_001790.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
insulin glargine
adult
child
diabetes mellitus
hypoglycemic agents
hypoglycemic agents
Cartridge
Pre-filled Pen Syringe
injections, subcutaneous
product surveillance, postmarketing
adolescent
aged
drug interactions
pregnancy
breast feeding
biosimilar pharmaceuticals
Insulin Glargine
Insulin Glargine

---
https://www.anses.fr/fr/content/r%C3%A9sistance-aux-antibiotiques-de-nouveaux-%C3%A9l%C3%A9ments-concernant-la-colistine
2016
false
false
false
France
French
drug resistance, bacterial
colistin
bacterial infections
risk assessment
china
chickens
swine
escherichia coli
salmonella enterica
drug resistance, bacterial
plasmids
environmental monitoring
humans
scientific and technical information

---
Summary Basis of Decision (SBD) for Amitiza
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00337
2016
false
Canada
French
English
summary of product characteristics
chronic idiopathic constipation
Chloride Channel Agonists
Chloride Channel Agonists
drug approval
canada
administration, oral
treatment outcome
Lubiprostone 24mcg capsule (product)
Lubiprostone
Lubiprostone
constipation
chronic disease
adult
clinical trials as topic
aged
lubiprostone

---
MIFEGYMISO - Summary Basis of Decision
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00239
2016
false
false
false
false
Canada
French
English
summary of product characteristics
canada
drug approval
drug antagonism
administration, oral
administration, buccal
misoprostol
misoprostol
mifepristone
mifepristone
abortifacient agents, nonsteroidal
abortifacient agents, nonsteroidal
abortifacient agents, steroidal
abortifacient agents, steroidal
abortion, Drug-Induced
risk assessment
drug evaluation
abortion, induced

---
http://www.rheuma-net.ch/download/Content_attachments/FileBaseDoc/Azathioprin03-2013F.pdf
2016
false
false
false
false
Switzerland
French
guidelines for drug use
azathioprine
antirheumatic agents
antirheumatic agents
rheumatic diseases
administration, oral
azathioprine
azathioprine

---
http://www.has-sante.fr/portail/jcms/c_2598638/fr/deltyba
http://www.has-sante.fr/portail/jcms/c_2598638/fr/deltyba-delamanide-antituberculeux
2016
false
France
French
treatment outcome
delamanid
delamanid
delamanid
OPC-67683
OPC-67683
antibiotics, antitubercular
antibiotics, antitubercular
orphan drug production
drug therapy, combination
tuberculosis, multidrug-resistant
tuberculosis, pulmonary
continuity of patient care
mycobacterium tuberculosis
adult
administration, oral
nitroimidazoles
nitroimidazoles
oxazoles
oxazoles
evaluation of the transparency committee
antibiotic therapy
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_2606854/fr/incruse
2016
false
false
false
France
French
adult
pulmonary disease, chronic obstructive
umeclidinium
umeclidinium
treatment outcome
umeclidinium bromide
administration, inhalation
muscarinic antagonists
muscarinic antagonists
bronchodilator agents
bronchodilator agents
evaluation of the transparency committee
GSK573719
GSK573719
quinuclidines
quinuclidines

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00209
2016
false
false
false
Canada
French
English
summary of product characteristics
administration, oral
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
risk assessment
adult
thyroid neoplasms
Differentiated Thyroid Gland Carcinoma
Refractory Carcinoma
treatment outcome
Cancer Progression
drug approval
drug evaluation, preclinical
protein-tyrosine kinases
lenvatinib
canada
Lenvatinib Mesylate
Lenvatinib Mesylate
neoplasm recurrence, local
neoplasm metastasis
lenvatinib
lenvatinib
phenylurea compounds
quinolines
phenylurea compounds
quinolines

---
Summary Basis of Decision (SBD) for Trulicity
Dulaglutide, 0.75 mg/0.5 mL and 1.5 mg/0.5 mL, solution, subcutaneous injection
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00244
2016
false
false
false
Canada
French
English
treatment outcome
summary of product characteristics
immunoglobulin fc fragments
recombinant fusion proteins
drug approval
hypoglycemic agents
hypoglycemic agents
glucagon-like peptides
adult
diabetes mellitus, type 2
drug therapy, combination
injections, subcutaneous
aged
hemoglobin A, glycosylated
drug evaluation, preclinical
canada
metformin
sulfonylurea compounds
insulin
Glucagon-Like Peptide-1 Receptor
dulaglutide
immunoglobulin fc fragments
recombinant fusion proteins
dulaglutide
dulaglutide

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003789/human_med_001949.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pegaspargase
pegaspargase
pegaspargase
Pegaspargase (product)
drug interactions
pregnancy
breast feeding
antineoplastic agents
antineoplastic agents
antineoplastic combined chemotherapy protocols
adult
adolescent
child
precursor cell lymphoblastic Leukemia-Lymphoma
injections, intramuscular
infusions, intravenous
product surveillance, postmarketing
drug monitoring
contraception
drug storage
drug evaluation, preclinical
asparaginase
polyethylene glycols
asparaginase
polyethylene glycols

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002661/human_med_001954.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
precursor cell lymphoblastic Leukemia-Lymphoma
asparaginase
asparaginase
asparaginase
antineoplastic agents
antineoplastic agents
drug approval
europe
drug interactions
pregnancy
breast feeding
L-asparaginase preparation (product)
antineoplastic combined chemotherapy protocols
infusions, intravenous
drug monitoring
product surveillance, postmarketing
L-asparaginase 10,000iu powder for injection solution 10mL vial (product)
child
adolescent
adult
infant, newborn
infant
contraception
drug evaluation, preclinical

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003898/human_med_001945.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
brivaracetam
brivaracetam
brivaracetam
europe
drug approval
drug therapy, combination
anticonvulsants
anticonvulsants
adult
adolescent
epilepsies, partial
drug interactions
pregnancy
breast feeding
administration, oral
infusions, intravenous
drug monitoring
product surveillance, postmarketing
contraception
aged
SV2A protein, human
drug evaluation, preclinical
injections, intravenous
brivaracetam
brivaracetam
pyrrolidinones
pyrrolidinones
membrane glycoproteins
nerve tissue proteins

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004124/human_med_001961.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
piperazines
piperazines
pregnancy
breast feeding
drug interactions
adult
carcinoma, non-small-cell lung
Advanced Malignant Neoplasm
neoplasm metastasis
mutation
receptor, epidermal growth factor
antineoplastic agents
antineoplastic agents
carcinoma, non-small-cell lung
genetic testing
administration, oral
protein kinase inhibitors
protein kinase inhibitors
Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitor
protein-tyrosine kinases
product surveillance, postmarketing
drug monitoring
contraception
drug evaluation, preclinical
osimertinib
osimertinib
osimertinib

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003938/human_med_001956.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
betula
plant extracts
plant bark
plant extracts
adult
administration, cutaneous
gels
Wound of skin (disorder)
burns
skin transplantation
wound healing
keratinocytes
wounds and injuries
product surveillance, postmarketing
drug monitoring
betulin
betulin
drug evaluation, preclinical
Dry extract (qualifier value)
Betulae cortex
triterpenes
triterpenes

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002771/human_med_001941.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Talimogene laherparepvec
Talimogene laherparepvec
drug approval
europe
drug interactions
pregnancy
breast feeding
adult
antineoplastic agents
antineoplastic agents
gene therapy
melanoma
neoplasm metastasis
Stage IV Skin Melanoma
melanoma, cutaneous malignant
Unresectable Malignant Neoplasm
oncolytic viruses
oncolytic viruses
injections, intralesional
herpesvirus 1, human
adjuvants, immunologic
adjuvants, immunologic
drug monitoring
product surveillance, postmarketing
contraception
drug evaluation, preclinical
drug storage
talimogene laherparepvec
genetic therapy

---
Eptifibatide Accord - eptifibatide
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004104/human_med_001946.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
French
English
syndication feed
drugs, generic
eptifibatide
drug interactions
pregnancy
breast feeding
drug therapy, combination
infusions, intravenous
injections, intravenous
recurrence
Eptifibatide 2mg/mL injection solution 10mL vial (product)
Eptifibatide 750micrograms/mL infusion solution 100mL vial (product)
Eptifibatide (product)
peptides
adult
myocardial infarction
angina, unstable
platelet aggregation inhibitors
treatment outcome
drug evaluation, preclinical
eptifibatide
eptifibatide
peptides
drug evaluation
package leaflet
summary of product characteristics

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004007/human_med_001944.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
English
French
syndication feed
biosimilar pharmaceuticals
Etanercept (product)
Non-radiographic axial spondyloarthritis
psoriasis
Etanercept
Etanercept
arthritis, rheumatoid
adult
chronic disease
child
adolescent
antirheumatic agents
pregnancy
breast feeding
treatment outcome
drug interactions
drug evaluation, preclinical
drug approval
drug compounding
arthritis, psoriatic
injections, subcutaneous
drug therapy, combination
spondylitis, ankylosing
immunologic factors
antirheumatic agents
recombinant fusion proteins
tumor necrosis factor-alpha
etanercept
receptors, tumor necrosis factor
summary of product characteristics
package leaflet
drug evaluation

---
E-mail
08/12/2017


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.